Correvio Pharma Correvio Pharma is a specialty pharmaceutical company engaged in developing therapeutics. | ![]() UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ||
Founding Date | Founding Date 2018 | Founding Date 1904 | Founding Date 1928 |
Type | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Vancouver, CA HQ Puteaux, FR Genève, CH Chadds Ford, US | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 133 | Employees 7,5692% decrease | Employees 9,052 |
Financial | |||
Revenue (est.) | Revenue (est.) $32.6m (FY, 2019) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods $9.8m (FY, 2019) | Cost of goods N/A | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit $22.8m (FY, 2019) | Gross profit $4.5b (FY, 2020) | Gross profit €7.2b (FY, 2025) |
Net income | Net income ($35.2m) (FY, 2019) | Net income N/A | Net income €1.6b (FY, 2025) |
Operating ⚠ | |||
Countries | Countries N/A | Countries 100 (Dec, 2020) | Countries 35 (FY, 2019) |

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company